InvestLog
ROIV Roivant Sciences Ltd. logo

ROIV Roivant Sciences Ltd.

Healthcare
$29.44+0.00%OpenMarket Cap: $21.18B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

9

Dispositions

10

Buy/Sell Ratio

0.90

Net Shares

-553,911

Shares Acquired

603,035

Shares Disposed

1,156,946

Total Bought ($)

$0.00

Total Sold ($)

$4.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Venker Ericofficer: President & Immunovant CEOSell200,000$30.271,613,063
Fri May 22Venker Ericofficer: President & Immunovant CEOSell200,000$3.854,444,834
Fri May 22Venker Ericofficer: President & Immunovant CEOSell34,483$32.411,613,063
Fri May 22Pulik Richardofficer: CFOSell18,962$32.41278,549
Wed Apr 22Venker Ericofficer: President & Immunovant CEOSell200,000$29.591,647,546
Wed Apr 22Venker Ericofficer: President & Immunovant CEOSell200,000$3.854,644,834
Wed Apr 22Pulik Richardofficer: CFOSell84,026$29.0884,026
Wed Apr 22Pulik Richardofficer: CFOSell60,644$0.00297,511
Wed Apr 22Humes Jenniferofficer: Chief Accounting OfficerSell29,173$0.00113,364
Wed Apr 22Humes Jenniferofficer: Chief Accounting OfficerSell27,157$29.0827,157
Tue Apr 21Oren IlandirectorSell95$29.83120,229
Tue Apr 21Oren IlandirectorSell896$0.00120,324
Tue Apr 21MOMTAZEE JAMES CdirectorSell94$29.83109,405
Tue Apr 21MOMTAZEE JAMES CdirectorSell469$0.00109,499
Tue Apr 21Epperly Melissa B,directorSell670$0.0016,474